OMER Forecast. What You Should Know.
OMER Historical Ratings and Targets
About Omeros Corporation
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell tr... OMER Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.